<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
11797-757-06
</NDCCode>
<PackageDescription>
10 SYRINGE in 1 CARTON (11797-757-06) > .3 mL in 1 SYRINGE (11797-757-02)
</PackageDescription>
<NDC11Code>
11797-0757-06
</NDC11Code>
<ProductNDC>
11797-757
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Enoxaparin Sodium
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Enoxaparin Sodium
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName>
INTRAVENOUS; SUBCUTANEOUS
</RouteName>
<StartMarketingDate>
20210401
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
ANDA
</MarketingCategoryName>
<ApplicationNumber>
ANDA076726
</ApplicationNumber>
<LabelerName>
Italfarmaco SpA
</LabelerName>
<SubstanceName>
ENOXAPARIN SODIUM
</SubstanceName>
<StrengthNumber>
30
</StrengthNumber>
<StrengthUnit>
mg/.3mL
</StrengthUnit>
<Pharm_Classes>
Heparin, Low-Molecular-Weight [CS], Low Molecular Weight Heparin [EPC]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2022-11-23
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20210401
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>